Clearbridge Health (SGX:1H3) YoY EBITDA Growth : -1,600.00% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Clearbridge Health's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -1,600.00%.

Clearbridge Health's EBITDA per Share for the six months ended in Dec. 2023 was S$-0.05.

Clearbridge Health YoY EBITDA Growth Historical Data

The historical data trend for Clearbridge Health's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearbridge Health YoY EBITDA Growth Chart

Clearbridge Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

69.44

236.36

-180.00

-333.33

Clearbridge Health Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial													-275.00	-80.00	57.14	88.89	-1,600.00

Clearbridge Health YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Clearbridge Health's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.052	-	-0.012)	/	\| -0.012 \|
=	-333.33 %

Clearbridge Health's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.051	-	-0.003)	/	\| -0.003 \|
=	-1,600.00 %

Clearbridge Health YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearbridge Health (SGX:1H3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177

Website

https://www.clearbridgehealth.com

Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health (SGX:1H3) Headlines

No Headlines